New digital platform aims to break the silence around hereditary cancer in families

NCT ID NCT04214210

Completed Knowledge-focused Sponsor: University of Basel Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a digital health platform to help people with a hereditary risk of breast and ovarian cancer share their genetic test results with family members. Researchers worked with 128 participants in Switzerland and Korea to see if the tool reduced distress and improved communication. The goal was to make it easier for relatives to learn about their own cancer risk and get tested.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm hereditary breast ovarian cancer syndrome hereditary neoplastic syndrome ovarian cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER HEREDITARY CANCER OVARIAN CANCER

Contacts and locations

Show contact details

Locations

HFR Fribourg - Hôpital cantonal

Fribourg, Canton of Fribourg, 1752, Switzerland
Hirslanden Clinic Des Grangettes

Geneva, Canton of Geneva, 1224, Switzerland
Hopital du Jura - Service d' Oncology

Delémont, Canton of Jura, 2800, Switzerland
Istituto Oncologico della Zvizzera Italiana

Bellinzona, 6962, Switzerland
Kantonalspital Winterthur

Winterthur, Canton of Zurich, 8401, Switzerland
Unite d'Oncogenetique et de Prevention des Cancers

Geneva, 1205, Switzerland
Universitatklinik fur Medizinische Onkologie, Inselspital

Bern, 3010, Switzerland
University Hospital Basel

Basel, 4056, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.